July 8, 2021
Douglas Gabriel says
- OPEN AND READ...!
Open and Read
There is NO variant, Not novel, NO pandemic
M∙CAM is the international leader in intellectual property-based financial risk management.
From auditing patent quality for governments and patent
offices, to providing state-of-the-art actuarial risk management
systems and solutions to the largest banks and insurance companies,
M∙CAM has established a global standard in patent quality and
commercial validity assessment and management.
M∙CAM has supported the modernization of
intellectual property, tax, and accounting laws through its work
with oversight agencies and policy makers.
He was the founding CEO of Mosaic Technologies Inc., a company that developed and commercialized advanced computational linguistics technologies, dynamic data compression and encryption technologies, electrical field transmission technology, medical diagnostics, and stealth/anechoic technology.
He was a founding member of Japans Institute for Interface Science & Technology.
He founded and served as Executive Director of the Charlottesville Venture Group.
He has served as a board member for,
As former Assistant Professor at the University of Virginias School of Medicine, Dr. Martin founded the University's first wholly-owned, for-profit, research and development and technology transfer corporation.
Engaged in domestic and international technology transfer, clinical research, and financing, this company pioneered new techniques innovation management that have become industry standards.
In 1999, Dr. Martin was appointed by the Governor of the
Commonwealth of Virginia to serve on the Joint Commission on
Technology and Science and has served the General Assembly and
Virginias Center for Innovative Technology on numerous occasions.
In addition to his academic work, Dr. Martin has closely advised
intellectual property based finance and investment programs in
India, China, Denmark, the European Union, the United Kingdom, South
Africa, the Islamic Republic of Iran, the United States, and the
United Arab Emirates.
He maintains active research in the fields of linguistic genomics, fractal financial risk modeling, as well as continuing his over 15 years of research in cellular membrane ionic signaling.